Publications - Page 5 sur 43 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Hypertension pulmonaire (HTP) 06/11/23
Large Vessel Vasculitis in a Young Woman with EIF2AK4-associated Pulmonary Capillary Hemangiomatosis/Pulmonary Veno-Occlusive Disease.

Michailidou D, Chen DL, Collins BF, George MP, Montani D, Rayner SG, Sirisak C, Leary PJ.

Am J Respir Crit Care Med. 2023 Sep 1;208(5):e29-e31.
Hypertension pulmonaire (HTP) 06/11/23
Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension.

Masson B, Saint-Martin Willer A, Dutheil M, Penalva L, Le Ribeuz H, El Jekmek K, Ruchon Y, Cohen-Kaminsky S, Sabourin J, Humbert M, Mercier O, Montani D, Capuano V, Antigny F.

Am J Physiol Lung Cell Mol Physiol. 2023 Aug 1;325(2):L246-L261.
Hypertension pulmonaire (HTP) 06/11/23
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.

Welch CL, Aldred MA, Balachandar S, Dooijes D, Eichstaedt CA, Gräf S, Houweling AC, Machado RD, Pandya D, Prapa M, Shaukat M, Southgate L, Tenorio-Castano J; ClinGen PH VCEP; Chung WK; International Consortium for Genetic Studies in Pulmonary Arterial Hypertension (PAH-ICON) at the Pulmonary Vascular Research Institute (PVRI).

Genet Med. 2023 Jul 5;25(11):100925.
Hypertension pulmonaire (HTP) 06/11/23
Pulmonary arterial hypertension.

Boucly A, Gerges C, Savale L, Jaïs X, Jevnikar M, Montani D, Sitbon O, Humbert M.

Presse Med. 2023 Jul 28;52(3):104168.
Hypertension pulmonaire (HTP) 06/11/23
Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart.

Saint-Martin Willer A, Santos-Gomes J, Adão R, Brás-Silva C, Eyries M, Pérez-Vizcaino F, Capuano V, Montani D, Antigny F.

J Physiol. 2023 Sep;601(17):3717-3737.
Hypertension pulmonaire (HTP) 06/11/23
Diagnosis and management of pulmonary veno-occlusive disease.

Solinas S, Boucly A, Beurnier A, Kularatne M, Grynblat J, Eyries M, Dorfmüller P, Sitbon O, Humbert M, Montani D.

Expert Rev Respir Med. 2023 Jul-Dec;17(8):635-649.
Hypertension pulmonaire (HTP) 06/11/23
Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management.

Olsson KM, Corte TJ, Kamp JC, Montani D, Nathan SD, Neubert L, Price LC, Kiely DG.

Lancet Respir Med. 2023 Sep;11(9):820-835.
Hypertension pulmonaire (HTP) 06/11/23
Updated Hemodynamic Definition and Classification of Pulmonary Hypertension.

Lechartier B, Kularatne M, Jaïs X, Humbert M, Montani D.

Semin Respir Crit Care Med. 2023 Dec;44(6):721-727.
Hypertension pulmonaire (HTP) 06/11/23
Sequential multimodal therapy in chronic thromboembolic pulmonary hypertension with mixed anatomical lesions: a proof of concept.

Jevnikar M, Solinas S, Brenot P, Lechartier B, Kularatne M, Montani D, Savale L, Garcia-Alonso C, Sitbon O, Beurnier A, Boucly A, Bulifon S, Seferian A, Roche A, Mercier O, Simonneau G, Fadel E, Humbert M, Jaïs X.

Eur Respir J. 2023 Nov 2;62(5):2300517.
Hypertension pulmonaire (HTP) 06/11/23
Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension

Kularatne M, Boucly A, Savale L, Solinas S, Cheron C, Roche A, Jevnikar M, Jaïs X, Montani D, Humbert M, Sitbon O.

Expert Opin Pharmacother. 2023 Oct 23:1-15.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

Large Vessel Vasculitis in a Young Woman with EIF2AK4-associated Pulmonary Capillary Hemangiomatosis/Pulmonary Veno-Occlusive Disease.

Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension.

Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.

Pulmonary arterial hypertension.

Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart.

Diagnosis and management of pulmonary veno-occlusive disease.

Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management.

Updated Hemodynamic Definition and Classification of Pulmonary Hypertension.

Sequential multimodal therapy in chronic thromboembolic pulmonary hypertension with mixed anatomical lesions: a proof of concept.

Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension